<DOC>
	<DOCNO>NCT00897962</DOCNO>
	<brief_summary>RATIONALE : Studying sample blood patient cancer laboratory may help doctor learn change occur identify biomarkers related cancer . PURPOSE : This research study look blood glycan biomarkers woman stage IV breast cancer .</brief_summary>
	<brief_title>Blood Glycan Biomarkers Women With Stage IV Breast Cancer</brief_title>
	<detailed_description>OBJECTIVES : - To profile serum glycan biomarkers woman metastatic stage IV breast cancer , healthy control , patient noncancer medical illness . - To determine whether serial serum glycan biomarkers correlate response metastatic disease treatment . OUTLINE : This multicenter study . Blood collect patient metastatic breast cancer , patient noncancerous illness , healthy volunteer . Samples analyze serum glycan biomarkers matrix-assisted laser desorption/ionization ( MALDI ) Fourier transform ion-cyclotron resonance mass spectrometry ( FT ICR MS ) method . Blood sample collect every 3 month 18 month patient metastatic breast cancer . Patients without cancer single sample collect .</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Patient participant Women 's Health Clinic , Internal Medicine Clinic , UC Davis Cancer Center , meet 1 follow criterion : Diagnosis stage IV metastatic breast cancer , receive active treatment chemotherapy , endocrine therapy , target therapy Patients/participants without cancer Healthy control see annual exam , meet follow criterion : No chronic disease Not regular prescribed medication Patient without cancer see Internal Medicine Clinic Hormone receptor status specify PATIENT CHARACTERISTICS : Menopausal status specify Not pregnant breast feed No active cancer PRIOR CONCURRENT THERAPY : See Disease Characteristics</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>stage IV breast cancer</keyword>
</DOC>